Fresenius Medical Care (ETR:FME), (NYSE:FMS) specializes in products and services for individuals undergoing dialysis due to chronic kidney failure. With operations spread across various countries, the company focuses on manufacturing dialysis machines, dialyzers, and related disposables, while also running a vast network of outpatient dialysis centers. Fresenius Medical Care aims to improve the quality of life for patients suffering from kidney failure by offering innovative and sustainable healthcare solutions. Their projects often include advancing dialysis technologies, enhancing treatment efficiency, and expanding their global footprint to make dialysis accessible to those in need. The company's ultimate objective is to set new standards in renal care, providing patients with comprehensive support throughout their treatment journey.